A Randomized, Double-Blind, Multicenter, Placebo- and Active Comparator-Controlled Study to Evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (STARDOM1).
Phase of Trial: Phase III
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Celecoxib/tramadol (Primary) ; Tramadol
- Indications Pain
- Focus Therapeutic Use
- Acronyms STARDOM1
- Sponsors Mundipharma Research
- 02 Jan 2017 Status changed from not yet recruiting to recruiting.
- 07 Dec 2016 New trial record